Xanthine oxidoreductase-IN-4

CAS No. 1026587-58-5

Xanthine oxidoreductase-IN-4( —— )

Catalog No. M36437 CAS No. 1026587-58-5

Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 57 In Stock
10MG 85 In Stock
25MG 144 In Stock
50MG 214 In Stock
100MG 308 In Stock
200MG 451 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Xanthine oxidoreductase-IN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.
  • Description
    Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor. Xanthine oxidoreductase-IN-4 has inhibitory activity against XOR with an IC50 value of 29.3 nM. Xanthine oxidoreductase-IN-4 can be used for the research of hyperuricemia.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Mice acute hyperuricemia modelDosage:5 mg/kg Administration:Oral Result:Reduced serum levels of uric acid significantly from 4 h after administration.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Xanthine Oxidase (XAO)
  • Recptor
    Xanthine Oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1026587-58-5
  • Formula Weight
    309.32
  • Molecular Formula
    C16H15N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1=CC=C(OCC)C=C1)(=O)C2=CC=C(C=C2)C=3NN=NN3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wen Peng, et al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947. ?
molnova catalog
related products
  • Tigulixostat

    Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.

  • Xanthine oxidoreduct...

    Xanthine oxidoreductase-IN-5 is an orally active inhibitor of xanthine oxidoreductase (XOR) with an IC50 of 55 nM. Xanthine oxidoreductase-IN-5 may be used in studies of acute hyperuricemia.

  • 8-Azaadenine

    8-Azaadenine is an inhibitor of xanthine oxidase with IC50 of 0.54 μM and Ki of 0.66 μM.